Hudson Frederick M. 4

What Happened Hudson Frederick M., a director of Supernus Pharmaceuticals, sold 5,369 shares in an open-market/private sale on March 12, 2026. The Form 4 reports a weighted-average price of $50.61 per share, for total proceeds of roughly $271,725. The filing classifies the transaction as a sale (code S).

Key Details

• Transaction date: 2026-03-12 (filed with the SEC on 2026-03-16; appears timely under the two-business-day Form 4 rule).
• Price: weighted average $50.61; reported range $50.45–$50.82 (shares were sold in multiple trades).
• Shares disposed: 5,369; total value ≈ $271,725.
• Shares owned after the transaction: not disclosed in the provided excerpt.
• Footnote: The filing notes the $50.61 figure is a weighted-average price and the reporting person will provide, upon request, the number of shares sold at each separate price within the stated range.

Context This was a sale by a company director, which is often routine and not necessarily a signal about company prospects. The filing does not indicate a 10% owner status, option exercise, gift, or a 10b5-1 plan in the provided details. Retail investors should view insider sales as one of many data points and consider overall insider activity and company fundamentals before drawing conclusions.